NDC 82718-2210-01: Minnerva II Lidocaine, Epinephrine .004 g/10g; .3 g/10g Gel, 10 g Tube
This is a package of 10 g of Minnerva II Lidocaine, Epinephrine .004 g/10g; .3 g/10g Gel from SofTap Inc, first listed with the FDA May 2022 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 82718-2210-1 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 82718 labeler · 2210 product · 1 package
- Package marketed since
- May 11, 2022
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2026
- Barcode (UPC-A, from the NDC)
- 3 8271822101 5
- FDA record last changed
- Nov 19, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
Minnerva II Lidocaine, Epinephrine is a topical gel containing lidocaine and epinephrine hydrochloride. Lidocaine is an amide local anesthetic commonly used to numb skin and soft tissue in minor procedures or to reduce pain from small wounds and irritation. Epinephrine is typically included to help constrict blood vessels and prolong the effect of the anesthetic. This product is marketed as an unapproved drug and has not received FDA approval.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 82718-2210-01 You're viewing this Main listing | 10 g in 1 TUBE | 2022-05-11 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Minnerva II .004 g/10g; .3 g/10gthis 82718-2210-01 | SofTap | 10 g | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
What it looks like
Where does this data come from?
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII HM4YQM8WRC
Chlorobutanol is a colorless crystalline chemical used as a preservative in medicines. It prevents bacterial and fungal growth to maintain product safety and shelf life.
-
UNII 63ZP7I1BQO
A plant-derived thickening agent made from xanthan gum that has been chemically modified. It helps give the medicine the right texture and consistency, and may act as a binder or stabilizer in tablets and liquids.
-
UNII PDC6A3C0OX
Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
-
UNII BU8V88OWIQ
Sodium bisulfate is a chemical salt that acts as a preservative and pH buffer in medications. It helps prevent spoilage and maintains the proper acidity level to keep the medicine stable.
-
UNII 451W47IQ8X
Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
-
UNII 4VON5FNS3C
Sodium metabisulfite is a preservative derived from sulfur compounds. It prevents microbial growth and oxidation in medicines, helping extend shelf life and maintain product stability.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
7 inactive ingredients listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from SofTap Inc labeler code 82718
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
USES On adults over 18 only Temporarily relieves pain due to cuts, scrapes, or abrasions LabelPage1
⏱️ Dosage and Administration ▾
DIRECTIONS For external use only. Prior to application, a sensitivity test is advised. Before applying, cleanse the skin with an alcohol-free or acetone-free cleanser. Apply 1-2 cc to the desired area for up to 6 times per day. Discontinue use if allergic reaction occurs. Store in a cool dark place (up to 80 degrees F) or refrigerate. LabelPage3
⚠️ Warnings ▾
WARNINGS KEEP OUT OF REACH OF CHILDREN If swallowed seek medical help or contact Poison Control Center immediately.
🧪 Active Ingredient ▾
DRUG FACTS ACTIVE INGREDIENTS (per ml) PURPOSE Lidocaine USP - 4% topical anesthetic Epinephrine HCl - 0.4% vasoconstrictor FrontLabel
🧪 Inactive Ingredients ▾
OTHER INGREDIENTS Deionized water, glycerin, sodium bisulphate, sodium metabisulfate, dehydroxanthan gum, chlorobutanol, sodium chloride
🎯 Purpose ▾
ACTIVE INGREDIENTS (per ml) PURPOSE Lidocaine USP - 4% topical anesthetic Epinephrine HCl - .04% vasoconstrictor
📄 Do Not Use ▾
DO NOT USE With occlusion If you have a known allergy or sensitivity to any ingredients. If pregnant or breastfeeding On large areas of the body In large quantities. Apply only 1-2ml to desired area If you have a history of liver disease or impairment If safety seal is broken before first use
📄 When Using This Product ▾
KEEP OUT OF The eye and mouth. If accidental contact occurs, you may feel burning or stinging. Wash with water or eyewash immediately.
If your eyes have pain, blurry vision, extreme sensitivity to light, or a feeling of sand in the eye, contact an eye care physician immediately. WHEN USING THIS PRODUCT You may not feel pain. Avoid sources of heat or injury.
You may have temporary rash, redness, swelling, or itching Contact your physician promptly if you notice any unusual effects such as dizziness or drowsiness, difficulty breathing, trembling, chest pain, or irregular heartbeat. Made in the USA for SofTap 550 N Canyons Pkwy Livermore, CA 94551 www.softaps.com InsideLabel1
📄 Keep Out of Reach of Children ▾
WARNINGS KEEP OUT OF REACH OF CHILDREN LabelPage4
📄 Package Label / Principal Display Panel ▾
Minnerva II Front of Tube
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
Listed without an FDA application
This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |